bcda20230914

0001437749-23-026045.txt : 20230915 0001437749-23-026045.hdr.sgml : 20230915 20230915171013 ACCESSION NUMBER: 0001437749-23-026045 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230913 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20230915 DATE AS OF CHANGE: 20230915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38999 FILM NUMBER: 231259420 BUSINESS ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 8-K 1 bcda20230914_8k.htm FORM 8-K bcda20230914_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 13, 2023

BIOCARDIA, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-38999		23-2753988
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

320 Soquel Way
Sunnyvale, California 94085

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (650) 226-0120

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001	BCDA	The Nasdaq Capital Market
Warrant to Purchase Common Stock	BCDAW	The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter) ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On September 13, 2023, BioCardia, Inc. (the “Company”) received a written notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the minimum bid price of the Company’s common stock had been below the $1.00 per share minimum requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until March 11, 2024, to regain compliance with the Minimum Bid Price Requirement. The Notice states that the Nasdaq staff will provide written notification that the Company has achieved compliance with Rule 5550(a)(2) if, at any time before March 11, 2024, the closing bid price of the Company’s common stock is $1.00 per share or more for a minimum of ten consecutive business days. The Notice has no immediate effect on the listing or trading of the Company’s common stock.

In the event the Company does not regain compliance with the Minimum Bid Price Requirement by March 11, 2024, the Company may be eligible for additional time to regain compliance. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, the Company will be granted an additional 180 calendar days to regain compliance. If the Company does not qualify for or fails to regain compliance during the second compliance period, then the Nasdaq staff will provide written notification to the Company that its common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel.

Additionally, as previously disclosed on the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on September 12, 2023, the Company earlier received a separate written notice from Nasdaq, which indicated that the Company was not in compliance with Nasdaq rules that require a minimum Market Value of Listed Securities, as defined by Nasdaq (“MVLS”), of $35 million (the “MVLS Requirement”). The Company was afforded an initial compliance period of 180 calendar days, which is set to expire on March 4, 2024. As of the date of this Current Report on Form 8-K, the Company remains out of compliance with the MVLS Requirement.

The Company intends to actively monitor the closing bid price of its common stock and MVLS and may, if appropriate, consider available options to regain compliance with the Minimum Bid Price Requirement and the MVLS Requirement.

There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during the 180-day compliance period ending March 11, 2024, secure an extension of the compliance period beyond March 11, 2024 or maintain compliance with any other Nasdaq listing requirements, including, without limitation, the MVLS Requirement.

Forward-looking statements

This Current Report on Form 8-K contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not purely historical regarding the Company’s or its management’s intentions, beliefs, expectations and strategies for the future, including statements regarding the Company’s ability to regain compliance with the Minimum Bid Price Requirement and the MVLS Requirement, the Company’s intentions to actively monitor the closing bid price of its common stock and its MVLS, and the Company’s plans to consider implementing available options to regain compliance with the Minimum Bid Price Requirement and the MVLS Requirement. All forward-looking statements included in this Current Report on Form 8-K are made as of the date of this report, based on information currently available to the Company, deal with future events, are subject to various risks and uncertainties, including the risk that the Company may not meet the Minimum Bid Price Requirement by March 11, 2024 or the MVLS Requirement by March 4, 2024 or, in both cases, in the future, the risk that the Company may not otherwise meet the requirements for continued listing under the Nasdaq Listing Rules, the risk that Nasdaq may not grant the Company relief from delisting if necessary, and the risk that the Company may not ultimately meet applicable Nasdaq requirements if any such relief is necessary, among other risks and uncertainties, and actual results could differ materially from those anticipated in those forward-looking statements. The risks and uncertainties that may cause actual results to differ materially from the Company’s current expectations are more fully described in the Company’s Annual Report on Form 10-K filed with the SEC on March 29, 2023, as amended, any subsequently filed Quarterly Reports on Form 10-Q, and its other reports, each as filed with the SEC. Except as required by law, the Company assumes no obligation to update any such forward-looking statement after the date of this report or to conform these forward-looking statements to actual results.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BIOCARDIA, INC.

/s/ Peter Altman, Ph.D.
Peter Altman, Ph.D.
President and Chief Executive Officer

Date: September 15, 2023

EX-101.SCH 2 bcda-20230913.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 3 bcda-20230913_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 bcda-20230913_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key Class of Stock [Axis] Class of Stock [Domain] CommonStock Custom [Member] WarrantToPurchaseCommonStock Custom [Member] EX-101.PRE 5 bcda-20230913_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information	Sep. 13, 2023
Document Information [Line Items]
Entity, Registrant Name	BIOCARDIA, INC.
Document, Type	8-K
Document, Period End Date	Sep. 13, 2023
Entity, Incorporation, State or Country Code	DE
Entity, File Number	001-38999
Entity, Tax Identification Number	23-2753988
Entity, Address, Address Line One	320 Soquel Way
Entity, Address, City or Town	Sunnyvale
Entity, Address, State or Province	CA
Entity, Address, Postal Zip Code	94085
City Area Code	650
Local Phone Number	226-0120
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity, Emerging Growth Company	false
Amendment Flag	false
Entity, Central Index Key	0000925741
CommonStock Custom [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock
Trading Symbol	BCDA
Security Exchange Name	NASDAQ
WarrantToPurchaseCommonStock Custom [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrant to Purchase Common Stock
Trading Symbol	BCDAW
Security Exchange Name	NASDAQ

XML 7 bcda20230914_8k_htm.xml IDEA: XBRL DOCUMENT 0000925741 2023-09-13 2023-09-13 0000925741 bcda:CommonStockCustomMember 2023-09-13 2023-09-13 0000925741 bcda:WarrantToPurchaseCommonStockCustomMember 2023-09-13 2023-09-13 false 0000925741 8-K 2023-09-13 BIOCARDIA, INC. DE 001-38999 23-2753988 320 Soquel Way Sunnyvale CA 94085 650 226-0120 false false false false Common Stock BCDA NASDAQ Warrant to Purchase Common Stock BCDAW NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 22 1 false 2 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.bcda.com/20230913/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports bcda20230914_8k.htm bcda-20230913.xsd bcda-20230913_def.xml bcda-20230913_lab.xml bcda-20230913_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bcda20230914_8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "bcda-20230913_def.xml" ] }, "inline": { "local": [ "bcda20230914_8k.htm" ] }, "labelLink": { "local": [ "bcda-20230913_lab.xml" ] }, "presentationLink": { "local": [ "bcda-20230913_pre.xml" ] }, "schema": { "local": [ "bcda-20230913.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 2, "memberStandard": 0, "nsprefix": "bcda", "nsuri": "http://www.bcda.com/20230913", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "bcda20230914_8k.htm", "contextRef": "d20238K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.bcda.com/20230913/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "bcda20230914_8k.htm", "contextRef": "d20238K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "bcda_CommonStockCustomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CommonStock Custom [Member]" } } }, "localname": "CommonStockCustomMember", "nsuri": "http://www.bcda.com/20230913", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "bcda_WarrantToPurchaseCommonStockCustomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantToPurchaseCommonStock Custom [Member]" } } }, "localname": "WarrantToPurchaseCommonStockCustomMember", "nsuri": "http://www.bcda.com/20230913", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.bcda.com/20230913/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001437749-23-026045-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-026045-xbrl.zip M4$L#!!0 ( $:)+U?ZX+"FG0, "@/ 1 8F-D82TR,#(S,#DQ,RYX M42LXRKCN58PBY2.WEW\^;I5:LH> $?5 V?5R87,ZBM7-ERMC# MP\/$KTRT6:&"^)1)Y;T0$+5XF_70#Z$8%KH"Z5]C[UXP6WG<>8,=4\EV&$.BID7>Q,QC1-Z MDD1;NHZ#GO-"5P0KQ8Z\2-'77!F#5;1+ M=2/M4>!1K(?A7M*#+D3&>PGT"Q.ABX"*IPDBN7-&+BH''[4IKF#)JQRS5ZD? M%<_E4D*&99Y# @"VY@#T&VX*618F53]0@;5IO3S8YV8:MMCC+?X<.H M;[8QS)72+NAH7>%E*=52^ZF_Z]+VPOL"2Q+NU)0;X=O%ZSN->R_5G=Q99S&D.=8I_ M9R 9+ \-!"E22;\)_[MH2@.'1H,4BY

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end